Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Odysight.ai Inc. (ODYS) Form 8-K — Aug 13, 2026

$ODYSForm 8-KItems 2.02, 9.01Filed Aug 13, 2026, 9:27 AM ET0001493152-26-037619Original filing

Odysight.ai reported first-half 2026 revenue of $0.5 million, down sharply from $2.4 million a year earlier, with the decline attributed to the absence of $1.86 million of Q1 2025 revenue from a Fortune 500 medical customer. Net loss widened to $9.5 million from $8.3 million. The company ended June 30, 2026 with approximately $17.6 million in cash and no debt, though cash declined from roughly $25.7 million at year-end 2025. Management expects revenues to be weighted toward the second half of 2026 as existing orders convert into deliveries.

Key figures

Revenue
502000
Guidance
Revenues expected to be weighted towards the second half of 2026 as existing orders convert into deliveries; Boeing purchase order revenue to be recognized on program milestones with the majority anticipated within the next twelve months.
Total Debt
0
Revenue Yoy
-79% (vs. $2,427 thousand in H1 2025)
Total Assets
21379000
Cash Position
17600000
Shares Outstanding
16806905
Shareholders equity
17392000
Backlog june 30 2026
14100000
Gross profit h1 2025
671000
Gross profit h1 2026
180000
Backlog as of release date
16450000
Operating expenses h1 2025
9700000
Operating expenses h1 2026
10000000
Prior year revenue h1 2025
2427000
Derecognized contract liability q1 2025
1690000
Q1 2025 one time revenue from fortune 500 medical customer
1860000

Price after filing

1 day: 0.0%7 days: -17.7%30 days: -15.2%

Close on the filing date to close N calendar days later (from $4.07). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.